Genetic alterations in mature B- and T-cell lymphomas - a practical guide to WHO-HAEM5

被引:1
|
作者
Lopez, Cristina [1 ,2 ,3 ]
Fischer, Anja [4 ]
Rosenwald, Andreas [5 ]
Ott, German [4 ]
Siebert, Reiner [6 ]
Kurz, Katrin S. [6 ]
机构
[1] Inst Invest Biomed August Pi i Sunyer IDIBAPS, Mol Pathol Lab, Barcelona, Spain
[2] Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain
[3] Univ Barcelona, Fonaments Clin, Barcelona, Spain
[4] Ulm Univ, Ulm Univ Med Ctr, Inst Human Genet, Ulm, Germany
[5] Univ Wurzburg, Inst Pathol, Wurzburg, Germany
[6] Robert Bosch Krankenhaus, Dept Clin Pathol, Stuttgart, Germany
基金
欧盟地平线“2020”;
关键词
B- and T-cell lymphomas; chromosomal rearrangements; somatic variants; copy number alterations; prognostic factors;
D O I
10.1515/medgen-2024-2005
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The identification of recurrent genomic alterations in tumour cells has a significant role in the classification of mature B- and T-cell lymphomas. Following the development of new technologies, such as next generation sequencing and the improvement of classical technologies such as conventional and molecular cytogenetics, a huge catalogue of genomic alterations in lymphoid neoplasms has been established. These alterations are relevant to refine the taxonomy of the classification of lymphomas, to scrutinize the differential diagnosis within different lymphoma entities and to help assessing the prognosis and clinical management of the patients. Consequently, here we describe the key genetic alterations relevant in mature B- and T-cell lymphomas.
引用
收藏
页码:59 / 73
页数:15
相关论文
共 50 条
  • [1] Genetic alterations in myeloproliferative and myelodysplastic/myeloproliferative neoplasms - a practical guide to WHO-HAEM5
    Kuehn, Constanze
    Hoerst, Katharina
    Kvasnicka, Hans M.
    Hochhaus, Andreas
    Reiter, Andreas
    MEDIZINISCHE GENETIK, 2024, 36 (01) : 31 - 38
  • [2] Classification and challenges in the histopathological diagnosis of peripheral T-cell lymphomas, emphasis on the WHO-HAEM5 updates
    Murga-Zamalloa, Carlos
    Inamdar, Kedar
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [3] Overview on WHO-HAEM5 and the diagnostic relevance of genetic alterations for the classification
    Haferlach, Claudia
    Ott, German
    Hoerst, Katharina
    Kuehn, Constanze
    Haferlach, Torsten
    Siebert, Reiner
    MEDIZINISCHE GENETIK, 2024, 36 (01) : 3 - 11
  • [4] Genetic studies in clonal haematopoiesis, myelodysplastic neoplasms and acute myeloid leukaemia - a practical guide to WHO-HAEM5
    Hoerst, Katharina
    Kuehn, Constanze
    Haferlach, Claudia
    Haferlach, Torsten
    Khoury, Joseph D.
    MEDIZINISCHE GENETIK, 2024, 36 (01) : 21 - 29
  • [5] Genetic alterations in chronic lymphocytic leukemia and plasma cell neoplasms - a practical guide to WHO HAEM5
    Tausch, Eugen
    Lopez, Cristina
    Stilgenbauer, Stephan
    Siebert, Reiner
    MEDIZINISCHE GENETIK, 2024, 36 (01) : 47 - 57
  • [6] Genetic alterations in lymphoblastic leukaemia<bold> / lymphoma - a practical guide to WHO HAEM5</bold>
    Steinemann, Doris
    Dawidowska, Malgorzata
    Russell, Lisa J.
    Harrison, Christine J.
    Goehring, Gudrun
    MEDIZINISCHE GENETIK, 2024, 36 (01) : 39 - 45
  • [7] Autologous or allogeneic transplantation in B- and T-cell lymphomas
    Schmitz, N.
    Nickelsen, M.
    Glass, B.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2012, 25 (01) : 61 - 73
  • [8] Panel Sequencing of primary cutaneous B- and T-cell Lymphomas
    Wobser, M.
    Maurus, K.
    Roth, S.
    Appenzeller, S.
    Goebeler, M.
    Rosenwald, A.
    Geissinger, E.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 : 77 - 77
  • [9] Epigenetic targets in B- and T-cell lymphomas: latest developments
    Ribeiro, Marcelo Lima
    Vinces, Salvador Sanchez
    Mondragon, Laura
    Roue, Gael
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2023, 14
  • [10] Prevalence and Prognostication of CD5+Mature T-Cell Lymphomas
    Elghawy, Omar
    Cao, Miao
    Xu, Jason
    Landsburg, Daniel J.
    Svoboda, Jakub
    Nasta, Sunita D.
    Chong, Elise A.
    Schuster, Stephen J.
    Thomas, Colin J.
    Carter, Jordan S.
    Tavakkoli, Montreh
    Ruella, Marco
    Barta, Stefan K.
    CANCERS, 2024, 16 (19)